Muutke küpsiste eelistusi

E-raamat: Hematology - Oncology Therapy

  • Formaat: 1888 pages
  • Ilmumisaeg: 16-May-2014
  • Kirjastus: McGraw-Hill Medical
  • Keel: eng
  • ISBN-13: 9780071837057
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 154,44 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: 1888 pages
  • Ilmumisaeg: 16-May-2014
  • Kirjastus: McGraw-Hill Medical
  • Keel: eng
  • ISBN-13: 9780071837057
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens

More than 500 treatment regimens

Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniformmanner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts,Hematology-Oncology Therapy integrates extensive informationthat is critical to both office- and hospital-based practice of hematology and oncology.

Hematology-Oncology Therapy is divided into three sections:

Oncology:
Provides detailed information about the administration, supportive care, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approvedchemotherapeutic regimens, drugs, and biological agents

Supportive Care, Drug Preparation, Complications, and Screening:
Consists of topics commonly encountered in clinical hematology-oncology practice, such as chemotherapy-induced nausea, oncologic emergencies, radiation complications, cancer pain management, cancer screening, and much more

Selected Hematologic Diseases:
Delivers an authoritative guide to therapy for the principal diseases in consultative hematology

This edition of Hematology-Oncology Therapy is enriched by the updating of all chapters as well as the addition of several new chapters; the new "Expert Opinion," which provides recommendations and guidance from experts on the use of treatment regimens; and inclusion of the latest regimens.

Arvustused

"This is a high quality book that provides a comprehensive overview of a large number of tumor types as well as issues in benign hematology. The quality is high, the information is concise, and the readability is better than that of many other guides in the field."--Doody's Review Service Doody's 20070202 "The authors have accomplished their goal of producing a readily available hematology and oncology reference for office-and hospital-based clinicians. Clinicians of all disciplines involved in the treatment of patients with hematology and oncology disorders would benefit from the addition of Hematology-Oncology Therapy to their library. It would also be beneficial to pharmacies specializing in chemotherapy preparation in both community clinics and hospitals. Students and postgraduate residents and fellows would also benefit from this reference book."--The Annals of Pharmacotherapy The Annals of Pharmacotherapy 20070201

Authors ix
Preface xvii
SECTION I ONCOLOGY
1
1 Adrenocortical Cancer
5(10)
Peter F. Lebowitz
Tito Fojo
2 Anal Cancer
15(9)
Irfan Jawed
John Marshall
3 Biliary: Gallbladder Cancer and Cholangiocarcinoma
24(12)
Tim Greten
Susanna Ulahannan
Werner Scheithauer
4 Bladder Cancer
36(12)
Andrea Apolo
Dean Bajorin
5 Brain Cancer
48(40)
Lyndon Kim
Howard Fine
6 Breast Cancer
88(103)
Rachel C. Jankowitz
Nancy E. Davidson
7 Carcinoma of Unknown Primary
191(12)
David R. Spigel
F. Anthony Greco
8 Cervical Cancer
203(26)
Peter G. Rose
9 Colorectal Cancer
229(74)
Julia Lee Close
Carmen Joseph Allegra
10 Endometrial Cancer
303(9)
Maurie Markman
11 Esophageal Cancer
312(33)
Jimmy Hwang
John Marshall
12 Gastric Cancer
345(37)
Jonas W. Feilchenfeldt
Manish A. Shah
13 Gestational Trophoblastic Neoplasia
382(12)
John R. Lurain
14 Head and Neck Cancers
394(74)
Pol Specenier
JB Vermorken
15 Hepatocellular Carcinoma
468(26)
Tim Greten
Nadine Abi-Jaoudeh
16 HIV-Related Malignancies
494(17)
Bruce J. Dezube
17 Leukemia, Acute Lymphoblastic (ADULT)
511(33)
Michael M. Boyiadzis
Ivan Aksentijevich
Judith Karp
18 Leukemia, Acute Myeloid
544(15)
Michael M. Boyiadzis
Ivan Aksentijevich
Judith Karp
19 Leukemia, Chronic Lymphocytic
559(22)
Patricia Kropf
Kenneth Foon
20 Leukemia, Chronic Myelogenous
581(26)
Michael W.N. Deininger
Brian J. Druker
21 Leukemia, Hairy Cell
607(7)
Martin S. Tallman
22 Lung Cancer
614(42)
Enriqueta Felip
Rafael Rosell
23 Lymphoma, Hodgkin
656(28)
Michael Fuchs
Dennis A. Eichenauer
Volker Diehl
24 Lymphoma, Non-Hodgkin
684(120)
Carla Casulo
Julia Schaefer-Cutillo
Jonathan W. Friedberg
Richard Fisher
25 Melanoma
804(22)
Ahmad A. Tarhini
Amanda L. Gillespie-Twardy
John M. Kirkwood
26 Mesothelioma
826(10)
Verna Vanderpuye
Anish Thomas
Nicholas J. Vogelzang
27 Multiple Myeloma
836(92)
Aldo Roccaro
Giada Bianchi
Irene M. Ghobrial
Kenneth C. Anderson
28 Ovarian Cancer
928(47)
Eddie Reed
29 Pancreatic Cancer
975(22)
Ramesh K. Ramanathan
Daniel D. Von Hoff
30 Pancreatic Endocrine Tumors
997(24)
Sara Ekeblad
Britt Skogseid
31 Pheochromocytoma
1021(5)
Karel Pacak
Tito Fojo
32 Prostate Cancer
1026(29)
Avni Shah
Wenhui Zhu
William L. Dahut
33 Renal Cell Cancer
1055(42)
Susan Bates
Olivier Rixe
34 Sarcomas
1097(83)
Brigitte Widemann
Tito Fojo
Jean-Yves Blay
35 Testicular Cancer
1180(14)
Darren R. Feldman
George J. Bosl
36 Thymic Malignancies
1194(11)
Arun Rajan
Giuseppe Giaccone
37 Thyroid Cancer
1205(18)
Ann Gramza
Sam Wells
38 Vaginal Cancer
1223(8)
Leslie Boyd
Franco Muggia
SECTION II SUPPORTIVE CARE, DRUG PREPARATION, COMPLICATIONS, AND SCREENING
1231(376)
39 Prophylaxis and Treatment of Chemotherapy-Induced Nausea and Vomiting
1233(8)
Thomas E. Hughes
40 Drug Preparation and Administration
1241(144)
David R. Kohler
41 Guidelines for Chemotherapy Dosage Adjustment
1385(36)
Pamela W. McDevitt
Tito Fojo
42 Antineoplastic Drugs: Preventing and Managing Extravasation
1421(16)
David R. Kohler
43 Indications for Growth Factors in Hematology-Oncology
1437(17)
Pamela W. McDevitt
James N. Frame
Lee S. Schwartzberg
44 Indications for Bone-Modifying Agents in Hematology-Oncology
1454(21)
Reem Abozena Shalabi
James N. Frame
45 Transfusion Therapy
1475(16)
Ashok Nambiar
Joseph E. Kiss
46 Oncologic Emergencies
1491(25)
Mauricio Burotto Pichun
Tito Fojo
47 Fever and Neutropenia
1516(9)
Jennifer Cuellar-Rodriguez
Juan C. Gea-Banacloche
48 Catheter-Related Bloodstream Infections: Management and Prevention
1525(5)
Naomi P. O'Grady
49 Venous Catheter-Related Thrombosis
1530(4)
Roy E. Smith
50 Complications and Follow-Up After Hematopoietic Cell Transplantation
1534(18)
Michael M. Boyiadzis
Juan C. Gea-Banacloche
Michael R. Bishop
51 Radiation Complications
1552(24)
Ramesh Rengan
Diana C. Stripp
Eli Glatstein
52 Cancer Pain: Assessment and Management
1576(14)
Ann Berger
53 Hospice Care and End-of-Life Issues
1590(5)
Charles F. von Gunten
David E. Weissman
54 Cancer Screening
1595(4)
Kathleen A. Calzone
Jennifer Eng-Wong
Sheila Prindiville
55 Genetics of Common Inherited Cancer Syndromes
1599(8)
Kathleen A. Calzone
Sheila Prindiville
SECTION III SELECTED HEMATOLOGIC DISEASES
1607(238)
56 von Willebrand Disease
1609(24)
Pier M. Mannucci
57 Hemophilia
1633(24)
Steven J. Jubelilirer
Margaret Ragni
58 The Hypercoagulable State
1657(12)
Jeffrey I. Zwicker
Kenneth A. Bauer
59 Heparin-Induced Thrombocytopenia
1669(20)
James N. Frame
John R. Bartholomew
60 Autoimmune Hemolytic Anemia
1689(34)
James N. Frame
61 Sickle Cell Disease: Acute Complications
1723(26)
James N. Frame
Griffin P. Rodgers
62 Aplastic Anemia
1749(8)
Michael M. Boyiadzis
Neal S. Young
63 Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome
1757(8)
Arafat Tfayli
Kiarash Kojouri
James N. George
64 Idiopathic Thrombocytopenic Purpura
1765(14)
Kiarash Kojouri
Arafat Tfayli
James N. George
65 Hemochromatosis
1779(7)
James C. Barton
66 Myeloproliferative Neoplasms
1786(40)
Naseema Gangat
Ayalew Tefferi
67 Myelodysplastic Syndromes
1826(19)
Michael M. Boyiadzis
Neal S. Young
Index 1845
McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide





McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide





McGraw-Hill authors represent the leading experts in their fields and are dedicated to improving the lives, careers, and interests of readers worldwide